Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with ...

For many years, health experts have been concerned about "food deserts," places where residents lack good nutritional options ...

This segment is sponsored by Eli Lilly and Company.Social media is flooded with advertisments for popular obestiy medications ...

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...

Obesity medications, once facing shortages, are now widely available. So how do consumers not get scammed into purchasing ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Racial disparities in childhood obesity have risen due to social determinants, food insecurity, and systemic barriers, ...

About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.

SKNY-1 was previously shown to achieve up to 30% weight loss, reverse nicotine craving, and preserve muscle mass in an animal model-and is designed to avoid the CNS side effects that halted earlier CB ...

Obesity rates for Black children and adolescents are 22.4% in the decade before the pandemic and 35% in the 2 years after the ...